Eye-cing on the cake

With a Dec. 17 PDUFA date for its Macugen pegaptanib coming up, Eyetech Pharmaceuticals Inc. put its money where its mouth is last week and took the logical next step: acquiring its own manufacturing

Read the full 346 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE